Increased protection against bovine tuberculosis in the brushtail possum (Trichosurus vulpecula) when BCG is administered with killed Mycobacterium vaccae
- 1 February 2002
- journal article
- Published by Elsevier BV in Tuberculosis
- Vol. 82 (1), 15-22
- https://doi.org/10.1054/tube.2001.0318
Abstract
No abstract availableKeywords
This publication has 33 references indexed in Scilit:
- Interactions between hormone‐mediated and vaccine‐mediated immunotherapy for pulmonary tuberculosis in BALB/c miceImmunology, 2000
- Immunological approaches to the control of tuberculosis in wildlife reservoirsVeterinary Immunology and Immunopathology, 2000
- Randomized Controlled Trial ofMycobacterium vaccaeImmunotherapy in Non–Human Immunodeficiency Virus–Infected Ugandan Adults with Newly Diagnosed Pulmonary TuberculosisThe Journal of Infectious Diseases, 2000
- Beyond BCG: the potential for a more effective TB vaccineMolecular Medicine Today, 1999
- Clinical and serological studies of tuberculosis patients in Argentina receiving immunotherapy with Mycobacterium vaccae (SRL 172)Respiratory Medicine, 1999
- Immunotherapy with Mycobacterium vaccae in patients with newly diagnosed pulmonary tuberculosis: a randomised controlled trialThe Lancet, 1999
- Route of BCG administration in possums affects protection against bovine tuberculosisNew Zealand Veterinary Journal, 1995
- Variation in protection by BCG: implications of and for heterologous immunityThe Lancet, 1995
- Effectiveness of BCG vaccination in protecting possums against bovine tuberculosisResearch in Veterinary Science, 1995
- Immunotherapy for TuberculosisClinical Immunotherapeutics, 1994